Growth Factors Market is expected to reach US$ 4.07 Billion by 2033 | Major key players - Novartis AG, Biocon Limited, Amgen Inc.

Market Size and Forecast:

The Global Growth Factors Market size reached US$ 2.06 Billion with rise of US$ 2.19 Billion in 2024 is expected to reach US$ 4.07 Billion by 2033, growing at a CAGR of 7.1%during the forecast period 2025-2033. The Market is expanding due to rising demand for regenerative medicine, stem cell therapies, and advanced wound healing solutions across healthcare sectors. According to DataM Intelligence

To Download a Free Sample PDF (Use Corporate email ID to Get Higher Priority) at: https://datamintelligence.com/download-sample/growth-factors-market?sz

The Growth Factors Market refers to the global industry focused on naturally occurring proteins that regulate cell proliferation, differentiation, and survival. These biomolecules play a crucial role in tissue regeneration, wound healing, and stem cell therapy. The market encompasses recombinant growth factors and related products used in pharmaceuticals, biotechnology, and regenerative medicine applications.

Industry Recent Developments: United States

✅ October 2025: The FDA approved a novel growth factor-based therapy for chronic wound healing, showing significant efficacy in diabetic foot ulcers.

✅ October 2025: A leading US biotech company launched a new recombinant growth factor for orthopedic applications, enhancing bone regeneration.

✅ October 2025: The National Institutes of Health allocated $150 million for growth factor research targeting neurodegenerative diseases.

Industry Recent Developments: Japan

✅ October 2025: Japan's Pharmaceuticals and Medical Devices Agency approved a new growth factor formulation for cartilage repair in osteoarthritis patients.

✅ October 2025: Takeda Pharmaceutical expanded its growth factor production facility to meet the rising global demand for regenerative medicine products.

✅ October 2025: A Japanese research consortium developed a novel growth factor delivery system aimed at targeted cancer therapy.

Get Customization in the report as per your requirements + Exclusive Bundle & Multi-User Discounts: https://datamintelligence.com/customize/growth-factors-market?sz

FDA Approvals (2025):

✅ Datopotamab deruxtecan (Datroway / Dato-DXd) - U.S. approval (Jan 17, 2025) for unresectable/metastatic HR-positive, HER2-negative breast cancer (and an accelerated approval expansion for EGFR-mutated NSCLC in June 2025). This drug targets tumor antigens in indications tied to epidermal growth-factor receptor biology and therefore influenced the growth-factor-targeted oncology segment.

✅ Paltusotine (Palsonify) - FDA approval (Sept 25, 2025) as the first once-daily oral therapy for acromegaly (a growth-hormone/IGF-1 disorder). This approval is a direct growth-factor/endocrine market event because acromegaly treatment acts by controlling growth-hormone / IGF-1 signalling.

Regulatory Approvals / Major regulatory decisions (2025):

✅ Datroway (datopotamab deruxtecan) - EU marketing authorization (April 2025). EMA activity around Dato-DXd (positive CHMP opinion / EU MMA) strengthened the drug's global regulatory footprint and impacted oncology programs tied to growth-factor receptor biology.

Mergers & Acquisitions (2025):

✅ Roche → 89bio (deal announced / tender activity in 2025) - Roche moved to acquire 89bio, the company developing pegozafermin, an FGF21 analogue for metabolic / MASH indications. That M&A directly targeted the FGF (fibroblast growth factor) therapeutic space and signalled big-pharma appetite for FGF21 programs.

✅ Sanofi → Blueprint Medicines (completed mid-2025) - a large biotech buy (completed July 2025) that expands Sanofi's kinase / receptor-targeted and rare-disease portfolio (Blueprint's assets include KIT-driven programs). While Blueprint is broader than classical "growth factors," KIT and receptor-tyrosine-kinase biology overlap the growth-factor/receptor landscape and the deal influenced strategic positioning in receptor/kinase markets.

Major Key Players:

F. Hoffmann-La Roche Ltd.
Eli Lilly and Company
Novartis AG
Biocon Limited
Thermo Fisher Scientific
Amgen Inc
Merck

Segments Covered in the Growth Factors Market:

By Type: Vascular Endothelial Growth Factor (VEGF), Epidermal Growth Factor (EGF), Fibroblast Growth Factor (FGF), Platelet-derived Growth Factor (PDGF), Insulin-like Growth Factor (IGF), Others.

By Application: Oncology, Dermatology & Wound Healing, Cardiovascular Disorders, Neurological Disorders, Orthopedics, Others.

By End User: Hospitals & Clinics, Biopharmaceutical Companies, Research & Academic Institutes, Contract Research Organizations (CROs).

Regional Analysis for Growth Factors Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=growth-factors-market

Chapter Outline:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Growth Factors market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Growth Factors Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Growth Factors market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Growth Factors Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of Growth Factors market?

➠ Who are the global key manufacturers of the Growth Factors Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the Growth Factors market opportunities and threats faced by the vendors in the global Growth Factors Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the Growth Factors market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.